Vanguard Capital Management’s Mesa Laboratories MLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$30.7M Sell
236,214
-1,243
-0.5% -$141K ﹤0.01% 2166
2026
Q2
$23.6M Buy
237,457
+4,814
+2% +$485K ﹤0.01% 2355
2026
Q1
$20.6M Buy
+232,643
New +$20M ﹤0.01% 2330

Other funds holding MLAB

Vanguard Capital Management's MLAB Position: Q3 2026 in Review

Vanguard Capital Management reduced its Mesa Laboratories (MLAB) stake by 0.52% in Q3 2026, selling an estimated $141K and leaving 236,214 shares worth $30.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2166.

Vanguard Capital Management first reported a position in MLAB in Q1 2026 and has held it in 3 quarters since. 184 funds tracked by Wall St. Rank hold MLAB as of Q3 2026.

  • Vanguard Capital Management held 236,214 shares of Mesa Laboratories worth $30.7M as of Q3 2026.
  • Vanguard Capital Management sold 1,243 Mesa Laboratories shares in Q3 2026, an estimated $141K.
  • Mesa Laboratories made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2166 holding.
  • Vanguard Capital Management first reported a position in Mesa Laboratories in Q1 2026 and has held it in 3 quarters since.
  • 184 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.